OBI Pharma, Inc.
# OBI Pharma, Inc.

OBI Pharma, Inc. (Chinese: 台灣浩鼎生技股份有限公司) (TWSE: 4174) is a bio-pharmaceutical company, based in Nangang District, Taipei, Taiwan.

## History

This company was formerly a subsidiary of Optimer Pharmaceuticals.

On 9 Feb 2007, its parent company Optimer Pharmaceuticals can buy/sell on Nasdaq Stock Exchange. At that time, its share price was US$8.50 per share.

On 15 May 2012, OBI Pharma, Inc. was approved to become a public company in Taiwan.

On 23 Mar 2015, it can do transaction formally on OTC in Taiwan R.O.C.

